We plan to begin the subject review in October 2019. We will perform this review in accordance with the Office of National Drug Control Policy Circular, “Accounting of Drug Control Funding and Performance Summary,” May 8, 2018. The Circular requires the DoD to provide a performance summary report to the Director, Office of National Drug Control Policy. The objective of the review is to attest to whether the FY 2019 DoD Performance Summary Report is presented, in all material respects, in accordance with the Circular.